Figure 3.

Timeline of patient's clinical course highlighting surgical excision, radiation, and MCPyV antibody panel AMERK results for the treatment and management of his MCC, as well as rituximab infusions for his paraneoplastic autoimmune encephalitis. Day 0 is set to his initial MCC diagnosis. Red: diagnoses; blue: AMERK titers; green: treatment interventions for MCC and encephalitis, including wide local excision, IMRT, and rituximab infusions (1 g); black: seizures; purple: latest follow-up scans and EEG.